MADIT-II
2002
Multicenter Automatic Defibrillator Implantation Trial II
In 1,232 patients with prior MI and an ejection fraction ≤ 30 %, a prophylactic implantable defibrillator reduced all-cause mortality compared with conventional therapy.
Result
Efficacy: All-cause mortalityHR 0.69
Below 1 favours prophylactic implantable defibrillator, above 1 favours conventional therapy.
- Absolute difference
- 5.6 points
The absolute difference is derived from the event rates.
- Subtopic
- ICD
- Design
- RCT
- Relevance
- Practice-defining: a trial the guidelines cite as evidence.
- Source
- Moss AJ, et al. N Engl J Med. 2002;346(12):877-883.doi 10.1056/NEJMoa013474
Discussion & critique
Shifted ICD selection to ejection fraction alone, abandoning electrophysiology testing. Defined the post-MI primary-prevention population.